
Epinote Plus 333mg/145mg Tablet CR
Marketer
Neuracle Lifesciences Pvt Ltd
Salt Composition
Sodium Valproate (333mg) + Valproic Acid (145mg)
Overview Epinote Plus 333mg/145mg Tablet CR
Epileptic seizures, characterized by recurrent fits and abnormal brain activity, are effectively managed by the dual-action medication, Epinote Plus 333mg/145mg CR tablets. This formulation calms nerve activity, thereby preventing seizure episodes. Administered with food, the dosage is individually determined by your physician, potentially increasing gradually until your condition stabilizes. Therapeutic effects may take weeks to fully manifest; consistent daily use is crucial. Discontinuing treatment without medical consultation risks increased seizure frequency and potential worsening of bipolar disorder. Commonly reported side effects include nausea and tremors; less frequent reactions may involve vomiting, headaches, hepatic impairment, and upper abdominal discomfort. While most side effects are transient, persistent or bothersome symptoms require immediate medical attention. Strategies to mitigate side effects exist. Prior to commencing treatment, disclose any pre-existing kidney or liver disease, meningitis, depression, or suicidal ideation. Comprehensive medication disclosure is essential, including contraceptive use, as interactions are possible. While use during pregnancy or breastfeeding necessitates careful consideration and potential dosage adjustments, it remains a possibility if deemed medically necessary. Avoid operating vehicles if drowsiness or dizziness occurs. Regular blood tests monitor therapeutic response. Alcohol consumption should be avoided as it may exacerbate side effects. Weight gain is a potential consequence; maintaining a balanced diet, limiting high-calorie snacks, and regular physical activity are recommended. Report any unusual mood shifts, new or worsening depression, or suicidal thoughts or behaviors to your physician immediately.
Uses of Epinote Plus 333mg/145mg Tablet CR
Seizure disorder
Major Benefits of Epinote Plus 333mg/145mg Tablet CR:
Follow your doctor's instructions precisely regarding the dosage and length of treatment for this medication. Ingest the Epinote Plus 333mg/145mg Tablet CR whole; do not fragment or chew it. Administer this medication with a meal.
Common Side effects of Epinote Plus 333mg/145mg Tablet CR:
- Nausea
- Tremors
How to use Epinote Plus 333mg/145mg Tablet CR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Epinote Plus 333mg/145mg Controlled-Release tablets with a meal.
How Epinote Plus 333mg/145mg Tablet CR works:
The extended-release tablet, Epinote Plus 333mg/145mg CR, contains a dual anticonvulsant formulation of valproic acid and sodium valproate.
SAFETY ADVICE
AlcoholUNSAFE
Combining Epinote Plus 333mg/145mg CR tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Epinote Plus tablets (333mg/145mg) pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Epinote Plus tablets (333mg/145mg) are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
Taking Epinote Plus 333mg/145mg Controlled-Release tablets may cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Epinote Plus 333mg/145mg CR tablets appear safe for individuals with kidney conditions. Existing evidence indicates dose modification may be unnecessary, but this is based on limited information. Always seek medical advice. Discuss any pre-existing kidney disease with your physician.
LiverCAUTION
Individuals with liver impairment should use Epinote Plus 333mg/145mg CR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Epinote Plus 333mg/145mg CR tablets are unsuitable for patients experiencing severe or active liver disease.
What if you forget to take Epinote Plus 333mg/145mg Tablet CR :
Should you forget to take your Epinote Plus 333mg/145mg CR tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Epinote Plus 333mg/145mg Tablet CR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Central Nervous System (CNS) Neurology |
